Analysts at Goldman Sachs upgrade McKesson MCK from "neutral" to "conviction buy." The target price for MCK has been raised from $70 to $80.
MCK’s shares dipped 0.59% to close at $66.10 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: EarningsLong IdeasUpgradesPrice TargetMarketsAnalyst RatingsTrading IdeasGoldmanHealth CareHealth Care Distributors
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in